Extract
We read with great interest the comments by R.S. Wallis on our article describing the first case of extensively drug-resistant tuberculosis (XDR-TB) treated with both delamanid and bedaquiline [1], as recommended by the European Respiratory Society hosted TB Consilium experts [2, 3].
Abstract
First case, concerns and challenges of treatment of severe XDR-TB with both delamanid and bedaquiline http://ow.ly/8e4l303i0LH
Footnotes
Conflict of interest: None declared.
- Received August 3, 2016.
- Accepted August 4, 2016.
- Copyright ©ERS 2016